Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers.

Zhu Q, Kurtzma SH, Hegde P, Tannenbaum S, Kane M, Huang M, Chen NG, Jagjivan B, Zarfos K.

Neoplasia. 2005 Mar;7(3):263-70.

2.
3.

Optical tomography with ultrasound localization for breast cancer diagnosis and treatment monitoring.

Zhu Q, Tannenbaum S, Kurtzman SH.

Surg Oncol Clin N Am. 2007 Apr;16(2):307-21. Review.

4.

US-guided optical tomography: correlation with clinicopathologic variables in breast cancer.

Choi JS, Kim MJ, Youk JH, Moon HJ, Suh HJ, Kim EK.

Ultrasound Med Biol. 2013 Feb;39(2):233-40. doi: 10.1016/j.ultrasmedbio.2012.09.014. Epub 2012 Dec 4.

PMID:
23219038
5.

Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction.

Zhu Q, Cronin EB, Currier AA, Vine HS, Huang M, Chen N, Xu C.

Radiology. 2005 Oct;237(1):57-66. Erratum in: Radiology. 2006 May;239(2):613.

6.

Early-stage invasive breast cancers: potential role of optical tomography with US localization in assisting diagnosis.

Zhu Q, Hegde PU, Ricci A Jr, Kane M, Cronin EB, Ardeshirpour Y, Xu C, Aguirre A, Kurtzman SH, Deckers PJ, Tannenbaum SH.

Radiology. 2010 Aug;256(2):367-78. doi: 10.1148/radiol.10091237. Epub 2010 Jun 22.

7.

Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization.

Zhu Q, Tannenbaum S, Hegde P, Kane M, Xu C, Kurtzman SH.

Neoplasia. 2008 Oct;10(10):1028-40.

8.

Enhanced resting-state dynamics of the hemoglobin signal as a novel biomarker for detection of breast cancer.

Graber HL, Al abdi R, Xu Y, Asarian AP, Pappas PJ, Dresner L, Patel N, Jagarlamundi K, Solomon WB, Barbour RL.

Med Phys. 2015 Nov;42(11):6406-24. doi: 10.1118/1.4932220.

9.

Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI.

Choe R, Corlu A, Lee K, Durduran T, Konecky SD, Grosicka-Koptyra M, Arridge SR, Czerniecki BJ, Fraker DL, DeMichele A, Chance B, Rosen MA, Yodh AG.

Med Phys. 2005 Apr;32(4):1128-39.

PMID:
15895597
10.

US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers.

Kim MJ, Su MY, Yu HJ, Chen JH, Kim EK, Moon HJ, Choi JS.

BMC Cancer. 2016 Feb 1;16:50. doi: 10.1186/s12885-016-2086-7.

11.

Monitoring the response to neoadjuvant hormone therapy for locally advanced breast cancer using three-dimensional time-resolved optical mammography.

Enfield L, Cantanhede G, Douek M, Ramalingam V, Purushotham A, Hebden J, Gibson A.

J Biomed Opt. 2013 May;18(5):56012. doi: 10.1117/1.JBO.18.5.056012.

PMID:
23698285
12.

Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer?

Pakalniskis MG, Wells WA, Schwab MC, Froehlich HM, Jiang S, Li Z, Tosteson TD, Poplack SP, Kaufman PA, Pogue BW, Paulsen KD.

Radiology. 2011 May;259(2):365-74. doi: 10.1148/radiol.11100699. Epub 2011 Mar 15.

13.

Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast.

Ueda S, Nakamiya N, Matsuura K, Shigekawa T, Sano H, Hirokawa E, Shimada H, Suzuki H, Oda M, Yamashita Y, Kishino O, Kuji I, Osaki A, Saeki T.

BMC Cancer. 2013 Oct 31;13:514. doi: 10.1186/1471-2407-13-514.

14.

Detecting angiogenesis in breast tumors: comparison of color Doppler flow imaging with ultrasound-guided diffuse optical tomography.

Zhu Q, You S, Jiang Y, Zhang J, Xiao M, Dai Q, Sun Q.

Ultrasound Med Biol. 2011 Jun;37(6):862-9. doi: 10.1016/j.ultrasmedbio.2011.03.010. Epub 2011 Apr 30.

PMID:
21531497
15.

Optical tomography of breast cancer-monitoring response to primary medical therapy.

Enfield LC, Gibson AP, Hebden JC, Douek M.

Target Oncol. 2009 Sep;4(3):219-33. doi: 10.1007/s11523-009-0115-z. Epub 2009 Sep 24. Review.

PMID:
19777322
16.

Diffuse optical tomography of breast carcinoma: can tumor total hemoglobin concentration be considered as a new promising prognostic parameter of breast carcinoma?

Xiao M, Jiang Y, Zhu Q, You S, Li J, Wang H, Lai X, Zhang J, Liu H, Zhang J.

Acad Radiol. 2015 Apr;22(4):439-46. doi: 10.1016/j.acra.2014.12.012.

PMID:
25753593
17.

Ultrasound-Guided Diffuse Optical Tomography for Predicting and Monitoring Neoadjuvant Chemotherapy of Breast Cancers: Recent Progress.

Xu C, Vavadi H, Merkulov A, Li H, Erfanzadeh M, Mostafa A, Gong Y, Salehi H, Tannenbaum S, Zhu Q.

Ultrason Imaging. 2016 Jan;38(1):5-18. doi: 10.1177/0161734615580280. Epub 2015 Apr 16.

18.

Imaging heterogeneous absorption distribution of advanced breast cancer by optical tomography.

Xu Y, Zhu Q.

J Biomed Opt. 2010 Nov-Dec;15(6):066007. doi: 10.1117/1.3505015.

19.
20.

Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography.

Zhu Q, DeFusco PA, Ricci A Jr, Cronin EB, Hegde PU, Kane M, Tavakoli B, Xu Y, Hart J, Tannenbaum SH.

Radiology. 2013 Feb;266(2):433-42. doi: 10.1148/radiol.12112415. Epub 2012 Dec 21.

Supplemental Content

Support Center